500 related articles for article (PubMed ID: 12481257)
1. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
2. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; van Bokhoven A; Johannes WU; Nordeen SK; Ogden LG
Prostate; 2006 Apr; 66(5):557-66. PubMed ID: 16372328
[TBL] [Abstract][Full Text] [Related]
3. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
Raschke M; Wähälä K; Pool-Zobel BL
Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
[TBL] [Abstract][Full Text] [Related]
4. Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP.
Mitchell JH; Duthie SJ; Collins AR
Nutr Cancer; 2000; 38(2):223-8. PubMed ID: 11525601
[TBL] [Abstract][Full Text] [Related]
5. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
7. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
Hutchins AM; Slavin JL; Lampe JW
J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188
[TBL] [Abstract][Full Text] [Related]
8. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
9. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
10. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
[TBL] [Abstract][Full Text] [Related]
11. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells.
Balabhadrapathruni S; Thomas TJ; Yurkow EJ; Amenta PS; Thomas T
Oncol Rep; 2000; 7(1):3-12. PubMed ID: 10601582
[TBL] [Abstract][Full Text] [Related]
12. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
15. Effects of phytoestrogens on the trophoblast tumour cell lines BeWo and Jeg3.
Plessow D; Waldschläger J; Richter DU; Jeschke U; Bruer G; Briese V; Friese K
Anticancer Res; 2003; 23(2A):1081-6. PubMed ID: 12820351
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
Zava DT; Duwe G
Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
[TBL] [Abstract][Full Text] [Related]
17. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
Su SJ; Yeh TM; Lei HY; Chow NH
Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
[TBL] [Abstract][Full Text] [Related]
18. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes.
Liew R; Williams JK; Collins P; MacLeod KT
J Pharmacol Exp Ther; 2003 Mar; 304(3):985-93. PubMed ID: 12604673
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines.
Xiang H; Schevzov G; Gunning P; Williams HM; Silink M
Nutr Cancer; 2002; 42(2):224-32. PubMed ID: 12416264
[TBL] [Abstract][Full Text] [Related]
20. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.
Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT
Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
